U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07367542) titled 'Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery' on Jan. 18.
Brief Summary: A Dual-Center, Randomized, Controlled, Blinded, Prospective Study on the Effects of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery
Study Start Date: Jan. 17
Study Type: INTERVENTIONAL
Condition:
Depression
Anxiety
S-ketamine
Breast Cancer
Intervention:
DRUG: Esketamine 0.3mg/kg
A single dose of 0.3 mg/kg esketamine is administered intravenously during anesthesia induction, with the infusion completed over 40 minutes.
DRUG: Normal Saline
Receiving the sam...